Conference abstract · 31 Aug 2020
Conference abstractPublished 2018
Anti-NMDA encephalitis
Uskudar University, Turkey
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Anti-NMDA receptor encephalitis was firstly described in 2007. Up-to this date more than 400 cases have been described, making the syndrome rather un-rare. It is an autoimmune disorder where the NMDA receptors are targeted. The disease may affect anyone at any age and any gender. The patients usually have a viral-like prodrome of lethargy, upper respiratory symptoms, headache, nausea, fever etc. The presenting symptoms of the syndrome are mainly psychiatric. The patients manifest various psychotic symptoms like delusions, disorganized thoughts and behaviors, paranoid ideation, hallucinations, mood lability and cognitive deterioration. After 1-3 weeks of neuropsychiatric symptoms, the patient suffers from neurological complications such as global alterations in consciousness, catatonic-like states, dysautonomia and seizures. The patients may need to be hospitalized for 3-4 months. Aggressive treatment with corticosteroids and immunotherapy is needed. Most patients respond to this treatment. However, they may have significant cognitive and behavioral abnormalities like deficits in executive functions, impulsivity and behavioral dis-inhibition and sleep disturbances that need further follow-up. Psychiatric and neurological symptoms are treated with psychotropic drugs as in other neuropsychiatric syndromes. Some patients may need neuro-rehabilitation. The diagnosis requires Cerebrospinal Fluid (CSF) work-up. In CSF lymphocytic pleocytosis, elevated protein and oligoclonal bands are found. Demonstrating antibodies against NMDA receptors in CSF and/or serum gives a solid diagnosis of the disease. Cranial Magnetic Resonance Imaging (MRI) may be normal in half of the cases. Electroencephalography (EEG) is usually abnormal with slowed and disorganized activity. In this session a review of anti-NMDA encephalitis will be presented in light of a case that was diagnosed and followed-up in our clinic. This is an important neuropsychiatric syndrome that may go unnoticed unless the physician follows-up the patient closely, runs in-depth neuropsychiatric tests and collaborates with other physicians.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Short communication · 18 May 2021
Anti-NMDA encephalitis: It is an autoimmune disorder where the NMDA receptors are targeted
Review article · 2013
Anti-NMDA Receptor Encephalitis
Conference abstract · 2016
Anti-NMDA receptor antibodies and CNS lupus
Article · 30 Jul 2025
Paraneoplastic Anti-NMDA Receptor Encephalitis Associated with Ovarian Teratoma: A Case Report
More from this journal
The newest in Journal of Immunological Techniques & Infectious Diseases.
Research article · 14 Feb 2025
A Pattern of Cytokine Response in Suspected HIV-Negative Tuberculous Meningitis Patients, a Study from Tertiary Neurocenter in India
Review article · 17 Jan 2025
Vitiligo is a Breakdown of the Melanocyte-Immune Tolerance
Short communication · 25 Sep 2024
Pediatric Infections: A Comprehensive Overview of Common Illnesses and Management
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Immunological Techniques & Infectious Diseases
- SubjectImmunology & Microbiology
- SubjectInfectious Diseases
- BylineArticles whose byline prints “Nevzat Tarhan”

